» Articles » PMID: 31471861

Leuprolide Acetate, a GnRH Agonist, Improves the Neurogenic Bowel in Ovariectomized Rats with Spinal Cord Injury

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2019 Sep 1
PMID 31471861
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Electromyographic studies have shown that external anal sphincter activity is modified in response to distension in animals with spinal cord injury. Gonadotropin-releasing hormone and its agonist leuprolide acetate have neurotrophic properties in animals with spinal cord injury.

Aim: This study was to determine the effects of leuprolide acetate treatment on electromyographic activity of the external anal sphincter and anorectal manometry in ovariectomized rats with spinal cord injury.

Methods: Adult ovariectomized rats were divided in three groups: (a) sham of spinal cord injury, (b) spinal cord injury treated with saline solution, and (c) spinal cord injury treated with leuprolide acetate. The spinal cord injury was induced by clamping at level T9. Leuprolide acetate dosage of 10 μg/kg was proctored intramuscular for 5 weeks, commencing the day after the lesion. Electromyography of the external anal sphincter, anorectal manometry, and volume of the cecum were evaluated in all groups.

Results: The electromyographic study of the external anal sphincter activity showed a significant improvement in injured rats treated with leuprolide acetate. Manometric analysis and cecum volume data obtained in animals with leuprolide acetate were very similar to those found in the sham group.

Conclusions: These results demonstrate that leuprolide acetate treatment improves the neurogenic colon in ovariectomized rats with spinal cord injury.

Citing Articles

Gonadotropin-releasing hormone and growth hormone act as anti-inflammatory factors improving sensory recovery in female rats with thoracic spinal cord injury.

Martinez-Moreno C, Calderon-Vallejo D, Diaz-Galindo C, Hernandez-Jasso I, Olivares-Hernandez J, Avila-Mendoza J Front Neurosci. 2023; 17:1164044.

PMID: 37360158 PMC: 10288327. DOI: 10.3389/fnins.2023.1164044.


The roles of GnRH in the human central nervous system.

Wickramasuriya N, Hawkins R, Atwood C, Butler T Horm Behav. 2022; 145:105230.

PMID: 35809386 PMC: 9990468. DOI: 10.1016/j.yhbeh.2022.105230.

References
1.
Mathias J, Clench M, Abell T, Koch K, Lehman G, Robinson M . Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease: a double-blind, placebo-controlled, randomized study. Dig Dis Sci. 1998; 43(6):1347-55. DOI: 10.1023/a:1018888631286. View

2.
Mathias J, Ferguson K, Clench M . Debilitating "functional" bowel disease controlled by leuprolide acetate, gonadotropin-releasing hormone (GnRH) analog. Dig Dis Sci. 1989; 34(5):761-6. DOI: 10.1007/BF01540350. View

3.
Krassioukov A, Eng J, Claxton G, Sakakibara B, Shum S . Neurogenic bowel management after spinal cord injury: a systematic review of the evidence. Spinal Cord. 2010; 48(10):718-33. PMC: 3118252. DOI: 10.1038/sc.2010.14. View

4.
Quintanar J, Salinas E, Gonzalez R . Gonadotropin-releasing hormone receptor in spinal cord neurons of embryos and adult rats. Neurosci Lett. 2009; 461(1):21-4. DOI: 10.1016/j.neulet.2009.06.028. View

5.
Ohlsson B . Gonadotropin-Releasing Hormone and Its Role in the Enteric Nervous System. Front Endocrinol (Lausanne). 2017; 8:110. PMC: 5461264. DOI: 10.3389/fendo.2017.00110. View